Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
AbbVie (NYSE:ABBV) Shares Down 2.5% - Here's Why
Is AbbVie Inc. (ABBV) One of the Debt Free Halal Stocks to Buy?
AbbVie (NYSE:ABBV) Trading Down 2.5% - Here's What Happened - Stock Observer
11 Debt Free Halal Stocks to Buy
If You Have $500,000 Saved at 60, Here's The Sort of Monthly Income You Can Count On
Viokace (AbbVie) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F
Nottingham biotech lands licensing deal with pharma giant AbbVie | TheBusinessDesk.com
Martingale Asset Management L P Sells 14,724 Shares of AbbVie Inc. $ABBV - Markets Daily
Invesco Ltd. Raises Stock Holdings in AbbVie Inc. $ABBV
Sei Investments Co. Increases Holdings in AbbVie Inc. $ABBV
Advisory Research Inc. Buys 9,880 Shares of AbbVie Inc. $ABBV
AbbVie Inc. (NYSE:ABBV) Receives Average Rating of "Moderate Buy" from Brokerages
AbbVie CEO Robert Michael got big pay hike in 2025
The Best Dividend Stocks to Buy and Hold Forever
Promising Pharmaceutical Stocks To Watch Now - March 12th - Stock Observer
AbbVie (NYSE:ABBV) Shares Down 1% - What's Next? - Daily Political
Avalo Therapeutics CEO Teases Q2 Top-Line Data for AVTX-009 Phase 2b HS LOTUS Trial at Conference - Markets Daily
AbbVie Inc. $ABBV Shares Sold by Van ECK Associates Corp
Douglass Winthrop Advisors LLC Grows Stock Position in AbbVie Inc. $ABBV - Markets Daily
Bokf Na Sells 8,422 Shares of AbbVie Inc. $ABBV - Markets Daily
AbbVie Inc. $ABBV Holdings Cut by Bokf Na | MarketBeat
RBC Capital Says AbbVie Inc. (ABBV) Growth Story Is Still in Early Stages
AbbVie Reports Promising Results from Phase 1 Study of ABBV-295
AbbVie Inc. $ABBV Holdings Cut by Bokf Na - Stock Observer
How The Narrative For AbbVie (ABBV) Is Shifting On Immunology Growth And Competition Risks
Bipolar Depression Market Expected to Witness Accelerated Expansion During the Forecast Period (2026-2036) Amid Advancements in Psychiatric Therapies | DelveInsight
Josh Brown: Biotech growth stocks immune to disruption risk
AbbVie's ABBV-295 Obesity Data Sparks Fresh Interest In Valuation
Market Downturn: 2 Stocks to Buy and Hold Through Any Storm
SageView Advisory Group LLC Buys 13,883 Shares of AbbVie Inc. $ABBV - Markets Daily
Mackenzie Financial Corp Sells 99,604 Shares of AbbVie Inc. $ABBV
Franklin Resources Inc. Trims Holdings in AbbVie Inc. $ABBV
AbbVie Inc. $ABBV Shares Sold by Franklin Resources Inc. - Stock Observer
Kepler Cheuvreux Suisse SA Takes $7.54 Million Position in AbbVie Inc. $ABBV - Daily Political
Immunophenotypic changes following menin inhibition in acute myeloid leukemia
abbvie hosts national media conclave on world glaucoma week
AbbVie's GLP-1 challenger shows early weight loss promise - Crain's Chicago Business
Capital International Investors Has $2.48 Billion Stock Holdings in AbbVie Inc. $ABBV - Markets Daily
Capital Research Global Investors Sells 34,749 Shares of AbbVie Inc. $ABBV - Markets Daily
Claret Asset Management Corp Has $27.53 Million Position in AbbVie Inc. $ABBV - Markets Daily
Is It Too Late To Consider AbbVie (ABBV) After A Strong Multi Year Run?
Capital Research Global Investors Sells 34,749 Shares of AbbVie Inc. $ABBV - Stock Observer
Elahere (AbbVie: mirvetuximab soravtansine-gynx) Market Research Report 2026: Epidemiology, Competitive Landscape, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F
Bank of Montreal Can Raises Stock Position in AbbVie Inc. $ABBV
ABBV: Future Returns Will Depend On Immunology Encore And Deal Optionality Uncertainty
Richard Bernstein Advisors LLC Cuts Stock Holdings in AbbVie Inc. $ABBV - Daily Political
B cell depletion in autoimmune disease: in vivo CAR-T or T cell engagers?
Real-world treatment patterns and visual outcomes of faricimab in patients with neovascular age-related macular degeneration in the UK at 12 months: the FARWIDE-nAMD study
AbbVie (NYSE:ABBV) Shares Down 1% Following Insider Selling
Biotech is resistant to AI disruption. Josh Brown likes these two stocks in the industry
REGENXBIO To Report Duchenne Muscular Dystrophy Trial Results In Early Q2 2026
AbbVie Trial Updates Add Context To Valuation And Growth Outlook
Sienna Gestion Boosts Stock Holdings in AbbVie Inc. $ABBV
AbbVie Reports Positive Topline Results In Phase 1 Study For ABBV-295 In Weight Management
AbbVie Inc. $ABBV Shares Purchased by Schroder Investment Management Group
Swiss National Bank Trims Stake in AbbVie Inc. $ABBV
AbbVie Inc. $ABBV Shares Acquired by LGT Group Foundation
Q4 Earnings Highs And Lows: Amgen (NASDAQ:AMGN) Vs The Rest Of The Therapeutics Stocks
AbbVie Inc. (ABBV) Announces Positive Topline Results from Phase 3 AFFIRM Study Evaluating SKYRIZI Subcutaneous Induction in Patients with Crohn's Disease
First Trust Advisors LP Sells 1,007,670 Shares of AbbVie Inc. $ABBV
Private Advisor Group LLC Sells 3,553 Shares of AbbVie Inc. $ABBV - Daily Political
LGT Group Foundation Increases Position in AbbVie Inc. $ABBV - Daily Political
Predictive biomarkers of response to chimeric antigen receptor (CAR) T-cell therapy for pan-haematologic cancer
This 5-Star ETF Pays Monthly Dividends and Has Never Missed in 19 Years
REGENXBIO Inc. (NASDAQ:RGNX) Q4 2025 Earnings Call Transcript
Natixis Advisors LLC Sells 4,569 Shares of AbbVie Inc. $ABBV
Korea Investment CORP Acquires 188,587 Shares of AbbVie Inc. $ABBV
AbbVie Inc. $ABBV Shares Bought by Rhenman & Partners Asset Management AB
Vinva Investment Management Ltd Purchases 31,451 Shares of AbbVie Inc. $ABBV - Stock Observer
Gabelli Funds LLC Decreases Stake in AbbVie Inc. $ABBV
Korea Investment CORP Purchases 188,587 Shares of AbbVie Inc. $ABBV - Stock Observer
Pharmaceutical Stocks To Research - March 7th - Stock Observer
Munich Reinsurance Co Stock Corp in Munich Invests $47.60 Million in AbbVie Inc. $ABBV - Markets Daily
Guardian Capital LP Grows Position in AbbVie Inc. $ABBV
Is AbbVie (ABBV) Still Priced Attractively After Its Strong Multi Year Share Price Run
Integrating genetics, age and imaging to predict treatment outcomes in neovascular age-related macular degeneration: a proof-of-concept study
AbbVie (NYSE:ABBV) SVP David Ryan Purdue Sells 5,230 Shares
Top Medical Stocks To Follow Today - March 6th - Markets Daily
Invest Like Warren Buffett with These ETFs
Integrity Advisory Solutions LLC Takes $747,000 Position in AbbVie Inc. $ABBV - Markets Daily
Edgar Lomax Co. VA Reduces Stock Position in AbbVie Inc. $ABBV
Weekly Investment Analysts' Ratings Changes for AbbVie (ABBV) - Daily Political
Crossmark Global Holdings Inc. Raises Holdings in AbbVie Inc. $ABBV
Berry Wealth Group LP Lowers Stake in AbbVie Inc. $ABBV
Avalo Therapeutics Highlights AVTX-009 Plan, Near-Term Phase II HS Data at Healthcare Conference - Daily Political
AbbVie Expands US AI Manufacturing As Risankizumab Trial Supports Valuation Gap
Did Positive Phase 3 SKYRIZI Crohn's Data Just Shift AbbVie's (ABBV) Immunology Investment Narrative?
Genomic structural variations contribute to inform prognosis in patients with cytogenetically normal acute myeloid leukemia
AbbVie (NYSE:ABBV) Trading Down 1.7% - What's Next?
REGENXBIO (NASDAQ:RGNX) Releases Earnings Results, Misses Estimates By $0.31 EPS - Stock Observer
Medical Stocks To Add to Your Watchlist - March 5th - Stock Observer
REGENXBIO Reports Fourth Quarter and Full Year 2025 Financia
Cambria Investment Management L.P. Makes New $729,000 Investment in AbbVie Inc. $ABBV - Stock Observer
AbbVie News
Adani Total Gas stock (ATGL) surged 37% in two days: What's going on with gas prices?
Starbucks (SBUX) shares analysis: Is Starbucks a good stock to buy right now?
Will Nvidia (NVDA) stock hit $300: What is the NVDA price prediction for 2030?
How to buy the top AI stocks in the Emirates: Microsoft (MSFT), Nvidia (NVDA), Alphabet stock
Most active stocks analysis: NVIDIA (NVDA), Tesla (TSLA), Amazon (AMZN) stock
Latest news
Show moreApple to Lower App Store Commission Fees in China: Strategic Move for Developer Ecosystem Growth
Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation
